Mtb regulators of essential and virulence-associated MmpLs
必需 MmpL 和毒力相关 MmpL 的 Mtb 调节因子
基本信息
- 批准号:9106596
- 负责人:
- 金额:$ 47.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerolAlgorithmsAntibioticsBacteriaBindingBinding SitesCarbonCarrier ProteinsCause of DeathCell WallCellsChIP-seqChronicCommunicable DiseasesComputer SimulationConsensusDNADNA BindingDNA-Protein InteractionDNase-I FootprintingDataDiglyceridesDockingElectrophoretic Mobility Shift AssayEstersFatty AcidsGene ExpressionGene Expression RegulationGenesHealthImmuneImmune responseIn VitroInfectionLigand BindingLigandsLipidsMaintenanceMembrane ProteinsMetabolicMicrobial BiofilmsModelingMolecularMycobacterium tuberculosisMycolic AcidNucleic Acid Regulatory SequencesNutrientOxidative StressPathogenesisPatientsPhysiologyPlayProtein Export PathwayProteinsRegulationRegulonResistanceRoleSite-Directed MutagenesisSourceStagingStimulusStressStructureSystemTherapeuticTranscriptional RegulationTrehaloseTuberculosisVirulenceWaxesWorkclinically relevantcombatinsightinterestlipid biosynthesislipid transportmycobacterialmycolatenoveloverexpressionpathogenprotein expressionprotein transportsmall moleculetranscription factortuberculosis granuloma
项目摘要
DESCRIPTION (provided by applicant): Despite the availability of antibiotics to combat Tuberculosis (TB), it is one of the leading causes of death due to infectious disease. Mycobacterium tuberculosis (Mtb) is a successful pathogen because it survives within immune cells and effectively establishes and maintains a latent TB infection. Therefore, understanding the mechanisms underlying the establishment or maintenance of dormancy can inform new strategies for TB therapeutics. Mycobacterial membrane protein large (MmpL) proteins are dedicated cell wall lipid transporters. Along with their accessory Mycobacterial membrane protein small (MmpS) proteins, these transporters are crucial players in mycobacterial physiology and pathogenesis. MmpL3 is essential; and MmpL4, MmpL5, MmpL7, MmpL8, MmpL10 and MmpL11 contribute to Mtb virulence. The function of the related proteins MmpL3 and MmpL11 that transport mycolic acid-containing lipids are of particular interest to us. MmpL3 transports trehalose monomycolate and is required for mycobacterial replication and viability. We showed that MmpL11 transports monomeromycolyl diacylglycerol and a mycolate ester wax. These are species of lipids that are sometimes referred to as "storage lipids" and are associated with dormant bacteria in vitro and accumulate in granulomas of TB patients. Therefore, it appears that MmpL11 plays a role in a clinically relevant, but poorly understood, aspect of Mtb pathogenesis. While significant advances have been made identifying MmpL substrates, the regulation of MmpL protein expression and their role in cell wall remodeling in different environmental conditions has not been explored. The proposed studies will characterize the structure and function of Mtb transcriptional regulators that control expression of essential and virulence-associated MmpL and MmpS proteins. Our preliminary data indicate that fatty acids directly modulate activity of some transcription factors. This suggests a model where Mtb can directly assess and respond to fatty acid intermediates, metabolic state and nutrient availability to control mmpL and mmpS gene regulation. By defining the molecular mechanisms underlying the regulation of MmpL transporters and identifying their regulons, we will generate novel insights into the transition between actively dividing Mtb and latent or non-replicating persistent Mtb.
描述(由适用提供):尽管抗生素可用于对抗结核病(TB),但它是由于传染病而导致的死亡原因之一。结核分枝杆菌(MTB)是一种成功的病原体,因为它在免疫核管内存活,并有效地建立和维持潜在的结核病感染。因此,了解休眠的建立或维持的基础机制可以为结核病治疗的新策略提供信息。分枝杆菌膜蛋白大(MMPL)蛋白是专用的细胞壁脂质转运蛋白。这些转运蛋白与它们的辅助分枝杆菌膜蛋白小(MMPS)蛋白相比,是分枝杆菌生理和发病机理中的关键参与者。 MMPL3是必不可少的; MMPL4,MMPL5,MMPL7,MMPL8,MMPL11和MMPL11有助于MTB病毒。我们特别感兴趣的含霉菌酸脂质的相关蛋白MMPL3和MMPL11的功能。 MMPL3运输海藻糖单霉菌酸盐,是分枝杆菌复制和生存能力所必需的。我们表明,MMPL11运输单霉素二酰基甘油和霉菌酯蜡。这些是脂质的物种,有时被称为“储存脂质”,并且在体外与休眠细菌有关,并在结核病患者的肉芽肿瘤中积聚。因此,MMPL11似乎在MTB发病机理的临床相关但知之甚少的方面中起作用。尽管已经确定了MMPL底物的重大进展,但尚未探索MMPL蛋白表达的调节及其在不同环境条件下细胞壁重塑中的作用。拟议的研究将表征MTB转录调节剂的结构和功能,该调节剂控制着基本和病毒相关的MMPL和MMPS蛋白的表达。我们的初步数据表明脂肪酸直接调节某些转录因子的活性。这表明MTB可以直接评估和响应脂肪酸中间体,代谢状态以及控制MMMPL和MMMPS基因调节的养分。通过定义调节MMPL转运蛋白调节的分子机制并确定其法规,我们将对积极分裂MTB与潜在或不重复的持久MTB之间的过渡产生新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Georgiana E. Purdy其他文献
M. tuberculosis Rv2252 encodes a diacylglycerol kinase involved in the biosynthesis of phosphatidylinositol mannosides (PIMs)
结核分枝杆菌 Rv2252 编码参与磷脂酰肌醇甘露糖苷 (PIM) 生物合成的二酰甘油激酶
- DOI:
10.1111/j.1365-2958.2006.05174.x - 发表时间:
2006 - 期刊:
- 影响因子:3.6
- 作者:
Róisín M. Owens;F. Hsu;B. VanderVen;Georgiana E. Purdy;Elizabeth Hesteande;P. Giannakas;J. Sacchettini;J. Mckinney;P. Hill;J. Belisle;B. Butcher;Kevin Pethe;D. Russell - 通讯作者:
D. Russell
Mycobacterium tuberculosis and the four-minute phagosome
结核分枝杆菌和四分钟吞噬体
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
D. Russell;Georgiana E. Purdy;R. Owens;K. Rohde;R. Yates - 通讯作者:
R. Yates
Georgiana E. Purdy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Georgiana E. Purdy', 18)}}的其他基金
The role and fate of Mtb storage lipids LCTAG and MWE
Mtb 储存脂质 LCTAG 和 MWE 的作用和命运
- 批准号:
9893601 - 财政年份:2020
- 资助金额:
$ 47.64万 - 项目类别:
Metabolite modulation of Mtb regulators of cell wall biogenesis
细胞壁生物发生的结核分枝杆菌调节剂的代谢调节
- 批准号:
10053297 - 财政年份:2016
- 资助金额:
$ 47.64万 - 项目类别:
Metabolite modulation of Mtb regulators of cell wall biogenesis
细胞壁生物发生的结核分枝杆菌调节剂的代谢调节
- 批准号:
9234364 - 财政年份:2016
- 资助金额:
$ 47.64万 - 项目类别:
TB Membrane Transporters and Intrinsic Resistance
结核病膜转运蛋白和固有耐药性
- 批准号:
8492015 - 财政年份:2011
- 资助金额:
$ 47.64万 - 项目类别:
TB Membrane Transporters and Intrinsic Resistance
结核病膜转运蛋白和固有耐药性
- 批准号:
8868006 - 财政年份:2011
- 资助金额:
$ 47.64万 - 项目类别:
TB Membrane Transporters and Intrinsic Resistance
结核病膜转运蛋白和固有耐药性
- 批准号:
8676638 - 财政年份:2011
- 资助金额:
$ 47.64万 - 项目类别:
TB Membrane Transporters and Intrinsic Resistance
结核病膜转运蛋白和固有耐药性
- 批准号:
8039513 - 财政年份:2011
- 资助金额:
$ 47.64万 - 项目类别:
TB Membrane Transporters and Intrinsic Resistance
结核病膜转运蛋白和固有耐药性
- 批准号:
8296272 - 财政年份:2011
- 资助金额:
$ 47.64万 - 项目类别:
Mycobacterial genes mediating resistance to bactericidal ubiquitin peptides
介导杀菌泛素肽抗性的分枝杆菌基因
- 批准号:
7514596 - 财政年份:2009
- 资助金额:
$ 47.64万 - 项目类别:
相似国自然基金
分布式非凸非光滑优化问题的凸松弛及高低阶加速算法研究
- 批准号:12371308
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
资源受限下集成学习算法设计与硬件实现研究
- 批准号:62372198
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于物理信息神经网络的电磁场快速算法研究
- 批准号:52377005
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
考虑桩-土-水耦合效应的饱和砂土变形与流动问题的SPH模型与高效算法研究
- 批准号:12302257
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向高维不平衡数据的分类集成算法研究
- 批准号:62306119
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Computer-assisted diagnosis of ear pathologies by combining digital otoscopy with complementary data using machine learning
通过使用机器学习将数字耳镜与补充数据相结合来计算机辅助诊断耳部病变
- 批准号:
10564534 - 财政年份:2023
- 资助金额:
$ 47.64万 - 项目类别:
Noninvasive Diagnostic Markers of Lower Respiratory Tract Infection in Mechanically Ventilated Patients
机械通气患者下呼吸道感染的无创诊断标志物
- 批准号:
10697471 - 财政年份:2023
- 资助金额:
$ 47.64万 - 项目类别:
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
合成生物信息天然产物抗癌剂的发现和表征
- 批准号:
10639302 - 财政年份:2023
- 资助金额:
$ 47.64万 - 项目类别:
Clinical decision support algorithm to optimize management of respiratory tract infection in children attending primary health facilities in Kilimanjaro Region, Tanzania
用于优化坦桑尼亚乞力马扎罗地区初级卫生机构儿童呼吸道感染管理的临床决策支持算法
- 批准号:
10734148 - 财政年份:2023
- 资助金额:
$ 47.64万 - 项目类别:
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
- 批准号:
10739603 - 财政年份:2023
- 资助金额:
$ 47.64万 - 项目类别: